The fact is, as the chairman points out, this bill passed 406 to 4, left the House 406 to 4. But, Mr. Chairman, I would say to my colleagues, please note, walk 100 yards down the hall to the other body. It went nowhere. One of the reasons it went nowhere is because of the provisions in this bill as well as the provisions dealing with liability restrictions. Do we want an Amtrak bill? Do we want the trains to continue running in the Northeast corridor? Do we want to see some legislation this year? Then we have to vote against the Quinn amendment and for the LaTourette amendment. Also, because the predictions that were made 2 years ago so eloquently in the debate about what would happen if these provisions were not included in the bill have proven not to come forth. Indeed, the so-called labor protections have resulted in less than slightly more than $1,000 per severed employee, not a great sum to Amtrak. So for those reasons, 406 to 4, yes, out of this House and the bill then went absolutely nowhere. Stalled on a siding.
Bob Wise: “The fact is, as the chairman points out, this bill passed 406 to 4, left the House 406 to 4. But, Mr. Chairman, I would…”
Editor's note · Context
Discussing the challenges faced by an Amtrak bill during House debate.
Share
More from Bob Wise
I rise to oppose this rule. We hear a lot about there being a surplus but the reality is it is in Social Security. I have the greatest respect and friendship for the distinguished chairman of the Committee on Rules. He is irrepressible…
Each one of us has one or two people that played major roles in our life that we can point to as a mentor in a formative stage in our life and development. In my life, I was fortunate enough to have Terry Sanford as one of those people. As…
I am one of the one-third of the Democrats that voted for the bill, but it seems to me it is the Republican leadership that is responsible for appointing conferees and moving it to conference. Why has that not happened?
Mr. Chairman, it is not to offer an amendment. I just want to assure the chairman and ranking member there was a statement I wanted to make very briefly concerning the Food and Drug Administration Modernization Act which was a significant…





